RESTASIS MULTIDOSE

Abbvie Corporation🇨🇦 Health Canada

Approval Id: 5314eff009ed5a89
Drug Approval Canada Name: RESTASIS MULTIDOSE
Product Name: RESTASIS MULTIDOSE
Status: Marketed
Status Date: 2023-07-19
Original Market Date: 2018-08-09
Din: 02476835
Drug Class: Human
Dosage Form: Emulsion
Route Of Administration: Ophthalmic
Schedule: Prescription
Ahfs: 52:08.00
Atc Original: S01XA18 CICLOSPORIN
Atc Name: s 01 xa 18
Aig Number: 0115996006
Company Name: Abbvie Corporation
Company Address: 8401 Trans-Canada Highway, Saint-Laurent, Quebec, Canada, H4S 1Z1
Company Detail Path: /organization/abbvie-corporation

CYCLOSPORINE

0.05 % / W/V

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

5314eff009ed5a89

Type

Standard